Universe Capsules Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.75 Cr
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.47 Cr
- Revenue Growth %
- Net Worth -2.09%
- Total Assets 263.10%
About Universe Capsules Biotech
Universe Capsules Biotech Private Limited (UCBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 2018 (Six years and one month 20 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.75 Cr.
The company currently has active open charges totaling ₹24.47 Cr.
Mani Sharma and Priyanka Sharma serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24303MP2018PTC047356
-
Company No.
047356
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Dec 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Universe Capsules Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mani Sharma
|
Director | 27-Dec-2018 | Current |
|
Priyanka Sharma
|
Director | 27-Dec-2018 | Current |
Financial Performance of Universe Capsules Biotech.
Universe Capsules Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 2.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universe Capsules Biotech?
Unlock access to Universe Capsules Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹24.47 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 24.27 Cr
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2024 | Others | ₹2.00 M | Open |
| 25 Jul 2023 | Bank Of India | ₹9.06 Cr | Open |
| 30 Aug 2021 | Bank Of India | ₹15.21 Cr | Open |
How Many Employees Work at Universe Capsules Biotech?
Unlock and access historical data on people associated with Universe Capsules Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universe Capsules Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universe Capsules Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.